ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SLN Silence Therapeutics Plc

535.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Silence Therapeutics Plc LSE:SLN London Ordinary Share GB00B9GTXM62 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 535.00 521.00 524.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Silence Therapeutics PLC Holding(s) in Company (1711D)

05/10/2018 2:16pm

UK Regulatory


TIDMSLN

RNS Number : 1711D

Silence Therapeutics PLC

05 October 2018

 
 
 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
 
 1. Identity of the issuer or the underlying                                     Silence Therapeutics 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: (ii) 
                                                                            ------------------------- 
 2 Reason for the notification (please tick the appropriate box or boxes): 
 An acquisition or disposal of voting rights                                              X 
------------------------------------------------------------------------------  --------------------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
------------------------------------------------------------------------------  --------------------- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
------------------------------------------------------------------------------  --------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------------------  --------------------- 
 Other (please 
  specify): 
-------------------------------------------------------------------------  ---  --------------------- 
 3. Full name of person(s) subject                                                      Ali Mortazavi 
  to the 
  notification obligation: (iii) 
                                                                            ------------------------- 
 4. Full name of shareholder(s)                                                         Ali Mortazavi 
  (if different from 3.):(iv) 
                                                                            ------------------------- 
 5. Date of the transaction and date                                                  04 October 2018 
  on 
  which the threshold is crossed 
  or 
  reached: (v) 
                                                                            ------------------------- 
 6. Date on which issuer notified:                                                    05 October 2018 
                                                                            ------------------------- 
 7. Threshold(s) that is/are crossed 
  or 
  reached: (vi, vii)                                                                           3%, 4% 
                                                                            ------------------------- 
 
 
 
 8. Notified details: 
 A: Voting rights attached to shares (viii, ix) 
 Class/type     Situation previous                Resulting situation after the triggering 
 of              to the triggering                 transaction 
 shares          transaction 
 
 if possible 
 using 
 the ISIN 
 CODE 
               --------------------------------  --------------------------------------------------------------------- 
                Number           Number           Number          Number of voting         % of voting rights 
                of                of               of shares       rights                   (x) 
                Shares            Voting 
                                  Rights 
               ---------------  ---------------  --------------  -----------------------  ---------------------------- 
                                                  Direct          Direct      Indirect     Direct        Indirect 
                                                                   (xi)        (xii) 
                   -----------    -----------    --------------  ----------  -----------  ------------  -------------- 
 GB00B9GTXM62   1937399          1937399          2899184         2899184                  4.08 
               ---------------  ---------------  --------------  ----------  -----------  ------------  -------------- 
 
 
 B: Qualifying Financial Instruments 
 Resulting situation after the triggering transaction 
 Type of            Expiration     Exercise/                        Number of voting           % of voting 
 financial           date (xiii)    Conversion Period                rights that may            rights 
 instrument                         (xiv)                            be 
                                                                     acquired if the 
                                                                     instrument is 
                                                                     exercised/ converted. 
                   -------------  -------------------------------  -------------------------  ------------------------ 
 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments (xv, xvi) 
 Resulting situation after the triggering transaction 
 Type of          Exercise       Expiration     Exercise/         Number of voting           % of voting rights 
 financial         price         date (xvii)    Conversion         rights instrument          (xix, xx) 
 instrument                                     period             refers to 
                                                (xviii) 
                 -------------  -------------  ----------------  -------------------------  -------------------------- 
                                                                                             Nominal       Delta 
                 -------------  -------------  ----------------  -------------------------  ------------  ------------ 
 
 
 Total (A+B+C) 
 Number of voting rights                            Percentage of voting rights 
                                                   ------------------------------------------------------------------- 
 2899184                                            4.08 
                                                   ------------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: (xxi) 
 
 
 Proxy Voting: 
 10. Name of the proxy holder: 
 
 11. Number of voting rights proxy holder will 
  cease 
  to hold: 
 
 12. Date on which proxy holder will cease to 
  hold 
  voting rights: 
 
 
 
  13. Additional information: 
 14. Contact name: 
                                                                             ---- 
 15. Contact telephone number: 
                                                                             ---- 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLUVAORWRARRAA

(END) Dow Jones Newswires

October 05, 2018 09:16 ET (13:16 GMT)

1 Year Silence Therapeutics Chart

1 Year Silence Therapeutics Chart

1 Month Silence Therapeutics Chart

1 Month Silence Therapeutics Chart

Your Recent History

Delayed Upgrade Clock